3-CPMTDopamine uptake inhibitor CAS# 14008-79-8 |
- BAM7
Catalog No.:BCC1397
CAS No.:331244-89-4
- Bendamustine HCl
Catalog No.:BCC1153
CAS No.:3543-75-7
- Capsaicin
Catalog No.:BCN1016
CAS No.:404-86-4
- Betulinic acid
Catalog No.:BCN5524
CAS No.:472-15-1
- Brassinolide
Catalog No.:BCC1438
CAS No.:72962-43-7
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 14008-79-8 | SDF | Download SDF |
PubChem ID | 203135 | Appearance | Powder |
Formula | C21H25Cl2NO | M.Wt | 378.34 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 75 mM in DMSO | ||
Chemical Name | 3-[(4-chlorophenyl)-phenylmethoxy]-8-methyl-8-azabicyclo[3.2.1]octane;hydrochloride | ||
SMILES | CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.Cl | ||
Standard InChIKey | FXKCQWIUITUJFU-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C21H24ClNO.ClH/c1-23-18-11-12-19(23)14-20(13-18)24-21(15-5-3-2-4-6-15)16-7-9-17(22)10-8-16;/h2-10,18-21H,11-14H2,1H3;1H | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | This cocaine analog binds with high affinity to the dopamine transporter (Ki = 30 nM) and blocks re-uptake of dopamine. However, it is a weak psychomotor stimulant and does not substitute for cocaine in addicted rats. |
3-CPMT Dilution Calculator
3-CPMT Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.6431 mL | 13.2156 mL | 26.4313 mL | 52.8625 mL | 66.0781 mL |
5 mM | 0.5286 mL | 2.6431 mL | 5.2863 mL | 10.5725 mL | 13.2156 mL |
10 mM | 0.2643 mL | 1.3216 mL | 2.6431 mL | 5.2863 mL | 6.6078 mL |
50 mM | 0.0529 mL | 0.2643 mL | 0.5286 mL | 1.0573 mL | 1.3216 mL |
100 mM | 0.0264 mL | 0.1322 mL | 0.2643 mL | 0.5286 mL | 0.6608 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- PB-22
Catalog No.:BCC1840
CAS No.:1400742-17-7
- Eucalyptin acetate
Catalog No.:BCN6216
CAS No.:14004-35-4
- 4μ8C
Catalog No.:BCC4754
CAS No.:14003-96-4
- Nystatin (Fungicidin)
Catalog No.:BCC4813
CAS No.:1400-61-9
- Dimethylolurea
Catalog No.:BCC8943
CAS No.:140-95-4
- 4-Allylanisole
Catalog No.:BCC8674
CAS No.:140-67-0
- Pentamidine isethionate
Catalog No.:BCC5644
CAS No.:140-64-7
- Nithiamide
Catalog No.:BCC4687
CAS No.:140-40-9
- Cinnamic acid
Catalog No.:BCN6217
CAS No.:140-10-3
- Palbinone
Catalog No.:BCN3930
CAS No.:139954-00-0
- Alpinone 3-acetate
Catalog No.:BCN7768
CAS No.:139906-49-3
- Drahebenine
Catalog No.:BCN7044
CAS No.:1399049-43-4
- Tannic acid
Catalog No.:BCN2643
CAS No.:1401-55-4
- AMG 925
Catalog No.:BCC5150
CAS No.:1401033-86-0
- 3'-Hydroxygynuramide II
Catalog No.:BCC8634
CAS No.:1401093-57-9
- PI-1840
Catalog No.:BCC5453
CAS No.:1401223-22-0
- ML 277
Catalog No.:BCC7976
CAS No.:1401242-74-7
- 15,16-Dihydroxyoctadeca-9Z,12Z-dienoic acid
Catalog No.:BCC8438
CAS No.:140129-22-2
- Pterisolic acid A
Catalog No.:BCN4842
CAS No.:1401419-85-9
- Pterisolic acid B
Catalog No.:BCN4843
CAS No.:1401419-86-0
- Pterisolic acid C
Catalog No.:BCN4838
CAS No.:1401419-87-1
- Pterisolic acid D
Catalog No.:BCN4839
CAS No.:1401419-88-2
- Pterisolic acid E
Catalog No.:BCN4841
CAS No.:1401419-89-3
- Pterisolic acid F
Catalog No.:BCN4840
CAS No.:1401419-90-6
Novel 4'-substituted and 4',4"-disubstituted 3 alpha-(diphenylmethoxy)tropane analogs as potent and selective dopamine uptake inhibitors.[Pubmed:7562926]
J Med Chem. 1995 Sep 29;38(20):3933-40.
A series of 4'-substituted and 4',4"-disubstituted 3 alpha-(diphenylmethoxy)tropane analogs were prepared as novel probes for the dopamine transporter. These compounds were evaluated in radiolabeled binding assays for the dopamine, norepinephrine, and serotonin transporters. All of these compounds monophasically displaced [3H]WIN 35,428 binding in rat caudate putamen with Ki values ranging from 11.8 to 2000 nM. The most potent compound in this series was 4',4"-difluoro 3 alpha-(diphenylmethoxy)tropane 7c with a Ki = 11.8 nM. All of the compounds inhibited dopamine uptake in rat caudate putamen (IC50 = 24-4456 nM) which correlated significantly (r = 0.907; p > 0.0001) with binding affinities at the dopamine transporter. None of the compounds demonstrated high-affinity binding at the norepinephrine (Ki > 4800 nM) or serotonin (Ki > 690 nM) transporters. Therefore, the most potent dopamine uptake inhibitors in this series were highly selective for the dopamine transporter. Preliminary behavioral studies of several of these analogs (7a-e) suggested that the compounds did not display a cocaine-like behavioral profile, despite their ability to inhibit dopamine uptake. The present data coupled with the observed differences from cocaine in structure-activity relationships suggested that the 3 alpha-(diphenylmethoxy)tropane analogs may be interacting at a different active site than cocaine on the dopamine transporter and that an additional binding domain might be exploited for the identification of potential therapeutics for the treatment of cocaine abuse.